-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Acorda Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Acorda Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$7.65M, a 3.62% decline year-over-year.
- Acorda Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$31.3M, a 11793% decline year-over-year.
- Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$31.1M, a 33508% decline from 2022.
- Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $93K.
- Acorda Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$30M, a 1.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)